A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The purpose of the study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo in treating mania during 3 weeks of treatment in patients with Bipolar I Disorder who suffer from manic or mixed episodes.
Epistemonikos ID: f133abba72866838cb0762bd49fd0409d3e531c6
First added on: May 04, 2024